Top Premarket Gainers

MT Newswires Live09-26

Telesis Bio (TBIO) shares increased more than two-fold pre-bell Thursday after the company said it teamed up with Beckman Coulter Life Sciences to create scalable biofoundries.

Pasithea Therapeutics (KTTA) shares surged 64% after the company said that its colorectal cancer drug PAS-004 demonstrated early potential signs of efficacy in a phase 1 trial.

NuCana (NCNA) shares rose 18% after the company said it received a new US patent covering the composition matter of its anti-cancer agent NUC-7738.

Micron Technology (MU) shares increased 16% after reporting improved fiscal Q4 financial results.

KE Holdings (BEKE) shares were up 14% following a 3.4% drop in the previous session.

Price: 4.8300, Change: +2.51, Percent Change: +108.19

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2470478052?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-26 20:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2470478052","market":"fut","top_or_hot":-1,"title":"Top Premarket Gainers","media":"MT Newswires Live","content":"<html><body><p> Telesis Bio (TBIO) shares increased more than two-fold pre-bell Thursday after the company said it teamed up with Beckman Coulter Life Sciences to create scalable biofoundries.</p><p>Pasithea <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (KTTA) shares surged 64% after the company said that its colorectal cancer drug PAS-004 demonstrated early potential signs of efficacy in a phase 1 trial.</p><p>NuCana (NCNA) shares rose 18% after the company said it received a new US patent covering the composition matter of its anti-cancer agent NUC-7738.</p><p>Micron Technology (MU) shares increased 16% after reporting improved fiscal Q4 financial results.</p><p>KE Holdings (BEKE) shares were up 14% following a 3.4% drop in the previous session.</p><p>Price: 4.8300, Change: +2.51, Percent Change: +108.19</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Premarket Gainers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Premarket Gainers\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-26 20:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Telesis Bio (TBIO) shares increased more than two-fold pre-bell Thursday after the company said it teamed up with Beckman Coulter Life Sciences to create scalable biofoundries.Pasithea Therapeutics (...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1852331112.SGD","symbol_name":"Blackrock World Technology Fund A2 SGD-H","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2470478052","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2470478052","pubTimestamp":1727352233,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Telesis Bio (TBIO) shares increased more than two-fold pre-bell Thursday after the company said it teamed up with Beckman Coulter Life Sciences to create scalable biofoundries.Pasithea Therapeutics (K","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1852331112.SGD":"Blackrock World Technology Fund A2 SGD-H","BK4504":"桥水持仓","BK4512":"苹果概念","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","BK4548":"巴美列捷福持仓","LU2286300806.USD":"Allianz Cyber Security AT Acc USD","LU0127658192.USD":"EASTSPRING INVESTMENTS GLOBAL TECHNOLOGY \"A\" (USD) ACC","LU0173614495.USD":"富达中国焦点A","LU0359201612.USD":"贝莱德中国基金A2","LU1316542783.SGD":"Janus Henderson Horizon Global Technology Leaders A2 SGD","LU0359202008.SGD":"Blackrock China Fund A2 SGD-H","MU":"美光科技","BK4554":"元宇宙及AR概念","LU1023057109.AUD":"BGF CHINA \"A2\" (AUDHDG) ACC","BK4532":"文艺复兴科技持仓","IE00B7SZLL34.SGD":"Legg Mason ClearBridge - Value A Acc SGD-H","LU0889566641.SGD":"FTSF - Templeton Shariah Global Equity A Acc SGD","BK4553":"喜马拉雅资本持仓","LU2250418816.HKD":"BGF WORLD TECHNOLOGY \"A\" (HKD) ACC","BK4585":"ETF&股票定投概念","LU0792757196.USD":"TEMPLETON SHARIAH GLOBAL EQUITY FUND \"A\" (USD) ACC","BK4505":"高瓴资本持仓","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","LU0642271901.SGD":"Janus Henderson Horizon Global Technology Leaders A2 SGD-H","NCNA":"Nucana PLC","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","LU2360106780.USD":"BGF WORLD TECHNOLOGY \"A4\" (USD) INC","LU0082616367.USD":"摩根大通美国科技A（dist）","GB00BDT5M118.USD":"天利环球扩展Alpha基金A Acc","LU0056508442.USD":"贝莱德世界科技基金A2","BK4566":"资本集团","BK4575":"芯片概念","LU0719512351.SGD":"JPMorgan Funds - US Technology A (acc) SGD","BEKE":"贝壳","BK4509":"腾讯概念","LU1688375341.USD":"贝莱德中国灵活股票基金","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","BK4121":"生命科学工具和服务","BK4527":"明星科技股","LU0081259029.USD":"UBS (LUX) EQUITY FUND - TECH OPPORTUNITY \"P\" (USD) ACC","BK4579":"人工智能","TBIO":"TELESIS BIO","BK4588":"碎股","BK4526":"热门中概股","BK4141":"半导体产品","KTTA":"Pasithea Therapeutics Corp.","LU1267930813.SGD":"FRANKLIN TEMPLETON SHARIAH GLOBAL EQUITY \"AS\" (SGD) ACC","LU0287142896.SGD":"Fidelity China Focus A-SGD","BK4079":"房地产服务"},"translate_title":"盘前涨幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TBIO":1,"NCNA":0.9,"KTTA":0.9,"BEKE":0.7,"MU":0.7},"content_text":"Telesis Bio (TBIO) shares increased more than two-fold pre-bell Thursday after the company said it teamed up with Beckman Coulter Life Sciences to create scalable biofoundries.Pasithea Therapeutics (KTTA) shares surged 64% after the company said that its colorectal cancer drug PAS-004 demonstrated early potential signs of efficacy in a phase 1 trial.NuCana (NCNA) shares rose 18% after the company said it received a new US patent covering the composition matter of its anti-cancer agent NUC-7738.Micron Technology (MU) shares increased 16% after reporting improved fiscal Q4 financial results.KE Holdings (BEKE) shares were up 14% following a 3.4% drop in the previous session.Price: 4.8300, Change: +2.51, Percent Change: +108.19","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2470478052"}